C. Pae

C. Pae, Ho-Kyoung Yoon, W. Bahk, 2016, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Psychological burdens are associated with young male transsexuals in Korea

C. Pae, I. Paik, Chul Lee, 2006, Psychiatry and clinical neurosciences.

Supersensitivity psychosis and aripiprazole tapering

C. Pae, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Quantification analysis of 123I‐IPT single photon emission computed tomography uptake in the striatum of parkinsonism with the standard magnetic resonance template

B. Choe, T. Suh, C. Pae, 2006, Psychiatry and clinical neurosciences.

Provoked bradycardia after paroxetine administration.

Soo-Jung Lee, C. Pae, I. Paik, 2003, General hospital psychiatry.

Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis

C. Pae, H. Lim, W. Bahk, 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

P. Masand, S. Jeon, A. Patkar, 2022, Psychiatry investigation.

Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysis.

A. Patkar, Changsu Han, C. Pae, 2020, Journal of psychiatric research.

Posttraumatic Embitterment Disorder in Patients with Chronic Kidney Disease

C. Pae, Yong Kyun Kim, Kyungsoo Lee, 2019, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Evidence-Based Treatment for Depressive Disorder

C. Pae, 2015, Psychiatry investigation.

Atypical antipsychotics as a possible treatment option for irritable bowel syndrome

P. Masand, Soo-Jung Lee, A. Patkar, 2013, Expert opinion on investigational drugs.

Reply to Dr Ng's comments on "A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation with An Extended Release Formulation of Methylphenidate in Outpatients with Treatment-Resistant Depression" [11]

P. Masand, A. Patkar, Changsu Han, 2008 .

Comment on: The relationship between statins and depression: a review of the literature

C. Pae, 2013, Expert opinion on pharmacotherapy.

Does Neurotropin-3 Have a Therapeutic Implication in Major Depression?

D. Steffens, A. Patkar, Changsu Han, 2008, The International journal of neuroscience.

Validation of the Korean version of the Generalized Anxiety Disorder 7 self‐rating Scale

S. Jeon, C. Pae, Ho-Kyoung Yoon, 2020, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Precision medicine for psychopharmacology: a general introduction

A. Patkar, Changsu Han, C. Pae, 2016, Expert review of neurotherapeutics.

Development of a Diverse Learning Experience for Diverse Psychiatry Resident Needs: A Four-Year Biological Psychiatry Curriculum Incorporating Principles of Neurobiology, Psychopharmacology, and Evidence-Based Practice

P. Masand, M. Jiroutek, R. Radhakrishnan, 2017, Psychiatry investigation.

Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram

P. Masand, Soo-Jung Lee, Changsu Han, 2014, Expert opinion on drug safety.

Duloxetine: an emerging evidence for fibromyalgia.

P. Masand, A. Patkar, Changsu Han, 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Duloxetine: a new psychopharmacologic treatment option for fibromyalgia?

P. Masand, C. Pae, 2008, Current psychiatry reports.

Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study

C. Pae, Y. Kweon, H. Lee, 2005, International clinical psychopharmacology.

An open pilot trial of olanzapine for delirium in the Korean population

J. Chae, C. Pae, Kwang-soo Kim, 2001, Psychiatry and clinical neurosciences.

Paroxetine for patients with undifferentiated somatoform disorder: A prospective, open-label, 8-week pilot study.

P. Masand, A. Patkar, Changsu Han, 2008, Current therapeutic research, clinical and experimental.

Pregabalin for treating bipolar mania.

C. Pae, 2009, Clinical neuropharmacology.

Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis.

A. Serretti, Soo-Jung Lee, A. Patkar, 2015, Journal of psychiatric research.

Comments on ‘What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?’

C. Pae, 2013, Psychiatry and clinical neurosciences.

Trace Amine Receptors and Mood Disorders

C. Pae, S.-M. Wang, 2016 .

Patient Preference and Satisfaction in Decision-Making Process

C. Pae, 2014, Journal of Korean medical science.

Psychometric Properties of the Patient Health Questionnaire–15 (PHQ–15) for Measuring the Somatic Symptoms of Psychiatric Outpatients

P. Masand, A. Patkar, Changsu Han, 2009 .

Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: A randomized, open-label, 12-week, parallel-group trial

P. Masand, A. Patkar, C. Pae, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder

P. Masand, A. Patkar, Changsu Han, 2008, Clinical drug investigation.

Will the Proteus sensor enhance adherence to aripiprazole or other antipsychotics?

P. Masand, Changsu Han, C. Pae, 2017, Expert review of neurotherapeutics.

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders

M. Zimmerman, S. Jeon, A. Patkar, 2017, PloS one.

No influence of FAT polymorphisms in response to aripiprazole

A. Serretti, L. Mandelli, A. Chiesa, 2010, Journal of Human Genetics.

P.306 Reduced chemokine ligand 1/GRO chemokine plasma levels are a possible biomarker of elderly depression

A. Serretti, F. Benedetti, C. Pae, 2019, European Neuropsychopharmacology.

A Randomized, Double-blind, Placebo-controlled Trial of Augmentation With an Extended Release Formulation of Methylphenidate in Outpatients With Treatment-Resistant Depression

P. Masand, A. Patkar, C. Pae, 2006, Journal of clinical psychopharmacology.

Polymorphisms of interleukin‐4 promoter and receptor gene for schizophrenia in the Korean population

J. Chae, C. Pae, Kwang-soo Kim, 2003, Psychiatry and clinical neurosciences.

Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder

C. Pae, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.

J. Chae, C. Pae, D. Kim, 2002, The Journal of clinical psychiatry.

Association study of catechol-O-methyltransferase gene polymorphism in Korean male alcoholics

C. Pae, Y. Kweon, H. Lee, 2005, Psychiatric genetics.

Interleukin-17 and Interleukin-22 Induced Proinflammatory Cytokine Production in Keratinocytes via Inhibitor of Nuclear Factor κB Kinase-α Expression

S. Woo, C. Pae, H. Park, 2012, Annals of dermatology.

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?

C. Pae, 2020, Chonnam medical journal.

A naturalistic study of risperidone treatment in seven affiliated university hospitals in Korea

J. Chae, C. Pae, D. Kim, 2003, Psychiatry and clinical neurosciences.

Comments on "Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial" by Dr Ko and colleagues.

C. Pae, 2009, Journal of clinical psychopharmacology.

Manganese superoxide dismutase (MnSOD: Ala–9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia

Soo-Jung Lee, A. Patkar, C. Pae, 2007, Psychiatry Research.

No association of TAP2 polymorphisms in Korean patients with schizophrenia

J. Chae, C. Pae, Kwang-soo Kim, 2004, Psychiatric genetics.

Association between antidepressants and breast/ovarian cancer

C. Pae, 2012, Expert opinion on pharmacotherapy.

Trends in Scientific Literature on Atypical Antipsychotics in South Korea: A Bibliometric Study

M. Pérez-Nieto, F. López-Muñoz, C. Álamo, 2013, Psychiatry investigation.

Association of sedative–hypnotic medications with suicidality

P. Masand, Soo-Jung Lee, A. Patkar, 2011, Expert review of neurotherapeutics.

Serotonin Receptor 2C -759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients

C. Pae, 2014, Psychiatry investigation.

In ﬂ uence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia

A. Serretti, A. Chiesa, Soo-Jung Lee, 2011 .

BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia

Soo-Jung Lee, C. Pae, I. Paik, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines.

Soo-Jung Lee, C. Pae, Sung-Hwan Park, 2006, International immunopharmacology.

Decreased Plasma Antioxidants in Schizophrenia

Soo-Jung Lee, C. Pae, I. Paik, 2004, Neuropsychobiology.

Monocyte chemoattractant protein-1 promoter –2518 polymorphism and schizophrenia in the Korean population

A. Serretti, Soo-Jung Lee, C. Pae, 2004, Psychiatric genetics.

No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample

A. Serretti, K. Aitchison, C. Pae, 2010, International journal of psychiatry in clinical practice.

A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?

A. Patkar, Changsu Han, C. Pae, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Potential role of lymphotoxin-alpha (tumor necrosis factor-beta) in the development of schizophrenia.

C. Pae, 2007, Medical hypotheses.

Association of estrogen receptor genes and schizophrenia: A preliminary study

C. Pae, J. Min, I. Paik, 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder

A. Patkar, C. Pae, H. Lim, 2007, Expert review of neurotherapeutics.

Relationship between the course of depression symptoms and the left ventricular mass index and left ventricular filling pressure in chronic haemodialysis patients

C. Pae, S. Ihm, Dai-Jin Kim, 2011, Nephrology.

Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability

P. Masand, C. Pae, M. Kritzer, 2022, Expert opinion on drug safety.

Monocyte chemoattractant protein-1 (MCP1) may play a role in depression

C. Pae, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

CACNA1C gene and schizophrenia: a case–control and pharmacogenetic study

A. Serretti, Soo-Jung Lee, A. Patkar, 2015, Psychiatric genetics.

Therapeutic Possibility of “Semax” for Depression

C. Pae, 2008, CNS Spectrums.

Why Systematic Review rather than Narrative Review?

C. Pae, 2015, Psychiatry investigation.

Treatment of Chronic Fatigue Syndrome: Findings, Principles and Strategies

C. Pae, S. Kempke, P. Luyten, 2008, Psychiatry investigation.

Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting

P. Masand, Soo-Jung Lee, A. Patkar, 2014, International clinical psychopharmacology.

Monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population

A. Serretti, Soo-Jung Lee, C. Pae, 2004, Psychiatry Research.

Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders

A. Patkar, C. Pae, I. Paik, 2007, Psychiatry Research.

Predictors of Early Worsening after Switch to Aripiprazole

A. Serretti, L. Mandelli, A. Chiesa, 2010, Clinical drug investigation.

No Influence of DTNBP1 Polymorphisms on the Response to Aripiprazole

A. Serretti, L. Mandelli, A. Chiesa, 2010, Neuropsychobiology.

Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole

A. Serretti, A. Chiesa, C. Pae, 2010, Psychiatry Research.

Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study

A. Serretti, L. Mandelli, A. Chiesa, 2009, European Neuropsychopharmacology.

Amisulpride versus Risperidone Treatment for Behavioral and Psychological Symptoms in Patients with Dementia of the Alzheimer Type: A Randomized, Open, Prospective Study

C. Pae, H. Lim, Chul Lee, 2007, Neuropsychobiology.

Can botulinum toxin improve mood in depressed patients?

Soo-Jung Lee, Changsu Han, C. Pae, 2012, Expert review of neurotherapeutics.

Selegiline transdermal system: Current awareness and promise

A. Patkar, Changsu Han, C. Pae, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comparison of Risperidone Orodispersible Tablet and Intramuscular Haloperidol in the Treatment of Acute Psychotic Agitation: A Randomized Open, Prospective Study

C. Pae, H. Lim, I. Paik, 2010, Neuropsychobiology.

Association of chronic divalproex sodium use and brain atrophy in Alzheimer’s disease

P. Masand, Soo-Jung Lee, A. Patkar, 2012, Expert review of neurotherapeutics.

Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population

A. Serretti, C. Pae, T. Jun, 2004, Psychiatry Research.

Rash and lamotrigine in bipolar patients

C. Pae, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder

C. Pae, 2014, Psychiatry investigation.

The predictor analysis of response to routine treatment in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Soo-Jung Lee, C. Pae, Y. Um, 2014, Neuro endocrinology letters.

Re‐administration of mirtazapine could overcome previous mirtazapine‐ associated restless legs syndrome?

J. Chae, Soo-Jung Lee, C. Pae, 2004, Psychiatry and clinical neurosciences.

Mirtazapine may have the propensity for developing a restless legs syndrome? A case report

J. Chae, C. Pae, Kwang-soo Kim, 2002, Psychiatry and clinical neurosciences.

Effect of quetiapine-XR on irritable bowel syndrome

C. Pae, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comments on MCP‐1 gene (SCYA2) and schizophrenia: A case‐control association study

C. Pae, 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Cognitive dysfunction in psychiatric illness: a neglected domain.

P. Masand, C. Pae, 2015, The Journal of clinical psychiatry.

Paroxetine-associated spontaneous sexual stimulation.

Soo-Jung Lee, C. Pae, I. Paik, 2005, International clinical psychopharmacology.

Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review

P. Masand, Soo-Jung Lee, A. Patkar, 2018, Chonnam medical journal.

Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy

A. Serretti, L. Mandelli, Soo-Jung Lee, 2007, Pharmacogenetics and genomics.

Paliperidone-associated atypical neuroleptic malignant syndrome: A case report

Soo-Jung Lee, Changsu Han, C. Pae, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis.

P. Masand, Soo-Jung Lee, A. Patkar, 2017, Journal of psychiatric research.

Irreversibility and Nonselectivity Irreversible and Nonselective Monoamine Oxidase Inhibitors : Phenelzine and Tranylcypromine

P. Masand, A. Patkar, C. Pae, 2013 .

Transdermal Selegiline: The New Generation of Monoamine Oxidase Inhibitors

P. Masand, A. Patkar, C. Pae, 2006, CNS Spectrums.

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise

P. Masand, A. Patkar, C. Pae, 2009, Current neuropharmacology.

Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders

C. Pae, Y. Matsuoka, K. Su, 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Profile of paliperidone extended release: review of efficacy and safety data

P. Masand, S. Srinivasan, C. Pae, 2008, Expert review of clinical pharmacology.

Tardive dystonic symptoms associated with aripiprazole treatment

C. Pae, H. Lim, Chul Lee, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study.

D. Steffens, S. Jo, I. Jo, 2008, Comprehensive psychiatry.

A case of brief psychosis associated with an arachnoid cyst

J. Chae, C. Pae, Kwang-soo Kim, 2002, Psychiatry and clinical neurosciences.

Case–control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics

A. Serretti, A. Chiesa, Soo-Jung Lee, 2012, European Archives of Psychiatry and Clinical Neuroscience.

TNFB polymorphism may be associated with schizophrenia in the Korean population

A. Serretti, J. Chae, C. Pae, 2003, Schizophrenia Research.

Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study

J. Woo, Y. Shin, C. Pae, 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1

P. Masand, A. Serretti, L. Mandelli, 2019, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples

P. Masand, A. Serretti, G. Forloni, 2017, Advances in Therapy.

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features

P. Masand, A. Serretti, G. Forloni, 2017, Journal of Molecular Neuroscience.

Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1

P. Masand, A. Serretti, L. Mandelli, 2017, Neuropsychobiology.

PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study

Soo-Jung Lee, Ashwin A. Patkar, Alessandro Serretti, 2016, Neuropsychobiology.

The Influence of AHI1 Variants on the Diagnosis and Treatment Outcome in Schizophrenia

P. Masand, A. Serretti, Soo-Jung Lee, 2015, International journal of molecular sciences.

Abelson Helper Integration Site-1 Gene Variants on Major Depressive Disorder and Bipolar Disorder

P. Masand, A. Serretti, Soo-Jung Lee, 2014, Psychiatry investigation.

DAOA Variants on Diagnosis and Response to Treatment in Patients with Major Depressive Disorder and Bipolar Disorder

A. Serretti, A. Chiesa, C. Pae, 2012, The Journal of international medical research.

Influence of BDNF Variants on Diagnosis and Response to Treatment in Patients with Major Depression, Bipolar Disorder and Schizophrenia

A. Serretti, A. Chiesa, Soo-Jung Lee, 2011, Neuropsychobiology.

DAOA variants and schizophrenia: Influence on diagnosis and treatment outcomes

A. Serretti, A. Chiesa, Soo-Jung Lee, 2011, International journal of psychiatry in clinical practice.

Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia

A. Serretti, A. Chiesa, Soo-Jung Lee, 2011, Psychiatry Research.

Investigational dopamine antagonists for the treatment of schizophrenia

P. Masand, Soo-Jung Lee, A. Patkar, 2017, Expert opinion on investigational drugs.

DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients

A. Serretti, L. Mandelli, A. Patkar, 2008, Neuroscience Letters.

Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study

S. Rozen, K. Krishnan, R. Kaddurah-Daouk, 2009, Psychopharmacology.

Delirium: Underrecognized and undertreated

P. Masand, A. Patkar, Changsu Han, 2008, Current treatment options in neurology.

Delirium: Where do we stand?

P. Masand, A. Patkar, Changsu Han, 2008, Current psychiatry reports.

Monocyte Chemoattractant Protein-1 Promoter –2518 Polymorphism May Have an Influence on Clinical Heterogeneity of Bipolar I Disorder in the Korean Population

Soo-Jung Lee, C. Pae, I. Paik, 2004, Neuropsychobiology.

Interleukin‐10 gene promoter polymorphism is not associated with schizophrenia in the Korean population

A. Serretti, C. Pae, Kwang-soo Kim, 2003, Psychiatry and clinical neurosciences.

Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population

J. Chae, C. Pae, Kwang-soo Kim, 2002, Psychiatry Research.

Fibromyalgia diagnosis: a review of the past, present and future

P. Masand, Soo-Jung Lee, A. Patkar, 2015, Expert review of neurotherapeutics.

Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment

W. Fleischhacker, Soo-Jung Lee, A. Patkar, 2011, Expert review of neurotherapeutics.

A review of the safety and tolerability of aripiprazole

C. Pae, 2009, Expert opinion on drug safety.

Pain and Depression: A Neurobiological Perspective of Their Relationship

Changsu Han, C. Pae, 2015, Psychiatry investigation.

The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials

A. Serretti, A. Patkar, C. Pae, 2008, International clinical psychopharmacology.

The effectiveness of mirtazapine in the treatment of post‐traumatic stress disorder: A 24‐week continuation therapy

J. Chae, C. Pae, W. Bahk, 2005, Psychiatry and clinical neurosciences.

Childhood abuse and treatment response in patients with irritable bowel syndrome: a post‐hoc analysis of a 12‐week, randomized, double‐blind, placebo‐controlled trial of paroxetine controlled release

A. Patkar, C. Pae, P. Mannelli, 2009, Journal of clinical pharmacy and therapeutics.

Open label study of the effect of amantadine on weight gain induced by olanzapine

J. Chae, C. Pae, Kwang-soo Kim, 2004, Psychiatry and clinical neurosciences.

No evidence for an association of the CTLA4 gene with bipolar I disorder

J. Chae, C. Pae, Y. Kweon, 2004, Psychiatry and clinical neurosciences.

A Severe Case of Bupropion Hydrochloride Extended-Release Monotherapy-Associated Visual Hallucinations and Delirium in a Female Patient with Major Depressive Disorder

C. Pae, 2010, CNS Spectrums.

Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.

P. Masand, A. Serretti, L. Mandelli, 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

P. Masand, Soo-Jung Lee, A. Patkar, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval

J. Beckmann, K. Kanyas, B. Lerer, 2005, European Journal of Human Genetics.

Omega-3 polyunsaturated fatty acids for major depressive disorder

C. Pae, K. Su, Sheng-Min Wang, 2013, Expert opinion on investigational drugs.

Beyond serotonin: newer antidepressants in the future

P. Masand, C. Pae, G. Rakesh, 2017, Expert review of neurotherapeutics.

Effectiveness of carbamazepine for benzodiazepine‐resistant impulsive aggression in a patient with frontal infarctions

C. Pae, 2008, Psychiatry and clinical neurosciences.

ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders

P. Masand, A. Serretti, L. Mandelli, 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

The Relationship between Depression, Anxiety, Somatization, Personality and Symptoms of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Soo-Jung Lee, C. Pae, Joon Chul Kim, 2014, Psychiatry investigation.

The Influence of Depression, Anxiety and Somatization on the Clinical Symptoms and Treatment Response in Patients with Symptoms of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

Soo-Jung Lee, C. Pae, Joon Chul Kim, 2014, Journal of Korean medical science.

Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report

Ho Young Son, H. Son, C. Pae, 2013, Endocrinology and metabolism.

Case–control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder

A. Serretti, A. Chiesa, Soo-Jung Lee, 2012, International journal of psychiatry in clinical practice.

Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia

A. Serretti, A. Chiesa, Soo-Jung Lee, 2012, Neuroscience Letters.

Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder

A. Serretti, A. Chiesa, Soo-Jung Lee, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Usefulness of the Patient Health Questionnaire-9 for Korean Medical Students

D. Steffens, A. Patkar, Changsu Han, 2014, Academic Psychiatry.

Human leukocyte antigen alleles in patients with bipolar disorder in the Korean population

J. Chae, C. Pae, T. Jun, 2002, Psychiatry and clinical neurosciences.

Risperidone in the treatment of mixed state bipolar patients: Results from a 24‐week, multicenter, open‐label study in Korea

K. Min, Y. Ahn, H. Cho, 2010, Psychiatry and clinical neurosciences.

Asenapine, Blonanserin, Iloperidone, Lurasidone, and Sertindole: Distinctive Clinical Characteristics of 5 Novel Atypical Antipsychotics

P. Masand, Soo-Jung Lee, A. Patkar, 2013, Clinical neuropharmacology.

Pramipexole augmentation in treatment-resistant major depressive disorder

C. Pae, 2014, Expert review of neurotherapeutics.

Aripiprazole in the Treatment of Depressive and Anxiety Disorders

A. Serretti, A. Patkar, C. Pae, 2008, CNS drugs.

Association of the serotonin transporter gene polymorphism with Korean male alcoholics.

C. Pae, Y. Kweon, H. Lee, 2005, Journal of psychiatric research.

The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: an exploratory study.

A. Serretti, Soo-Jung Lee, C. Pae, 2014, Journal of psychosomatic research.

Depression and Somatic Symptoms May Influence on Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Preliminary Study

Soo-Jung Lee, C. Pae, Joon Chul Kim, 2014, Psychiatry investigation.

The impact of depression and somatic symptoms on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: a preliminary study in a naturalistic treatment setting

C. Pae, J. Koh, J. C. Kim, 2014, International journal of clinical practice.

Investigation of an epistastic effect between a set of TAAR6 and HSP‐70 genes variations and major mood disorders

A. Serretti, A. Patkar, C. Pae, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

TAAR 6 and HSP-70 variations associated with bipolar disorder

A. Serretti, L. Mandelli, C. Pae, 2009, Neuroscience Letters.

Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment

A. Serretti, A. Patkar, C. Pae, 2009, European Neuropsychopharmacology.

The Impact of Heat Shock Protein 70 Gene Variations on Clinical Presentation and Outcome in Schizophrenic Inpatients

A. Serretti, L. Mandelli, D. De Ronchi, 2009, Neuropsychobiology.

The relationship between fibromyalgia and major depressive disorder: a comprehensive review

P. Masand, A. Patkar, Changsu Han, 2008, Current medical research and opinion.

History of depressive and/or anxiety disorders as a predictor of treatment response: A post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia

P. Masand, A. Patkar, C. Pae, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release

P. Masand, A. Patkar, Changsu Han, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population

A. Serretti, Soo-Jung Lee, C. Pae, 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Curcumin as a putative antidepressant

P. Masand, Soo-Jung Lee, H. Seo, 2015, Expert review of neurotherapeutics.

Influence of TAAR6 polymorphisms on response to aripiprazole

A. Serretti, L. Mandelli, A. Chiesa, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study

A. Serretti, L. Mandelli, D. De Ronchi, 2008, European Psychiatry.

Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia

A. Serretti, L. Mandelli, C. Pae, 2008, European Archives of Psychiatry and Clinical Neuroscience.

Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample

P. Masand, A. Serretti, L. Mandelli, 2018, Advances in Therapy.

Interaction analysis between 5-HTTLPR and TNFA −238/−308 polymorphisms in schizophrenia

A. Serretti, P. Artioli, C. Pae, 2006, Journal of Neural Transmission.

Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.

Changsu Han, C. Pae, T. Tang, 2015, Journal of psychiatric research.

Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia

A. Serretti, A. Chiesa, Soo-Jung Lee, 2012, Neuroscience Letters.

Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder

A. Serretti, L. Mandelli, D. Steffens, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Heat-shock protein-70 genes and response to antidepressants in major depression

A. Serretti, L. Mandelli, Soo-Jung Lee, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia

A. Serretti, P. Artioli, Soo-Jung Lee, 2005, Neuroscience Research.

Report on IL‐10 gene polymorphism at position –819 for major depression and schizophrenia in Korean population

J. Chae, C. Pae, Kwang-soo Kim, 2002, Psychiatry and clinical neurosciences.

Paliperidone: a review of clinical trial data and clinical implications.

W. Fleischhacker, Soo-Jung Lee, A. Patkar, 2012, Clinical drug investigation.

Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study

Y. Shim, H. Kim, C. Pae, 2011, International Journal of Impotence Research.

Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis

P. Masand, S. Jeon, A. Patkar, 2017, Journal of clinical psychopharmacology.

Fluoxetine‐induced mania in an Asian patient

Soo-Jung Lee, C. Pae, I. Paik, 2004, Psychiatry and clinical neurosciences.

Association between Estrogen Receptor Gene Polymorphisms and Depression in Post-Menopausal Women: A Preliminary Study

C. Pae, J. Min, I. Paik, 2010, Psychiatry investigation.

Bipolar disorder and plasticity: a key target for new treatment

C. Pae, Sheng-Min Wang, 2022, Biomarkers in Bipolar Disorders.

Vilazodone for the Treatment of Depression: An Update

P. Masand, Soo-Jung Lee, A. Patkar, 2016, Chonnam medical journal.

Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study

Y. Shin, C. Pae, K. Namkoong, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Effects of mirtazapine in patients with post‐traumatic stress disorder in Korea: a pilot study

J. Chae, C. Pae, Kwang-soo Kim, 2002, Human psychopharmacology.

Tianeptine combination for partial or non‐response to selective serotonin re‐uptake inhibitor monotherapy

C. Pae, B. Koo, Seunghwan Lee, 2013, Psychiatry and clinical neurosciences.

A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial

P. Masand, A. Serretti, L. Mandelli, 2018, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role

A. Serretti, Soo-Jung Lee, A. Patkar, 2017, Journal of Molecular Neuroscience.

Medical comorbidity and alcohol dependence

C. Pae, P. Mannelli, 2007, Current psychiatry reports.

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

P. Masand, Soo-Jung Lee, A. Patkar, 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

P. Masand, Soo-Jung Lee, A. Patkar, 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Naturalistic observation on the hepatic enzyme changes in patients treated with either risperidone or olanzapine alone

Soo-Jung Lee, C. Pae, H. Lim, 2005, International clinical psychopharmacology.

Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly

P. Masand, A. Serretti, F. Benedetti, 2019, European Archives of Psychiatry and Clinical Neuroscience.

Birth order and sibling sex ratio in homosexual transsexual South Korean men: Effects of the male‐preference stopping rule

R. Blanchard, C. Pae, K. Zucker, 2007, Psychiatry and clinical neurosciences.

Possible association between –G308A tumour necrosis factor-&agr; gene polymorphism and major depressive disorder in the Korean population

A. Serretti, J. Chae, C. Pae, 2003, Psychiatric genetics.

Long-term treatment of adjunctive quetiapine for bipolar mania

Soo-Jung Lee, C. Pae, I. Paik, 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.

P. Masand, A. Patkar, Changsu Han, 2008, Primary care companion to the Journal of clinical psychiatry.

Do We Need to Consider Ethno-cultural Variation in the Use of Atypical Antipsychotics for Asian Patients with Major Depressive Disorder?

Changsu Han, C. Pae, 2013, CNS Drugs.

Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: A retrospective study

P. Masand, J. Chae, S. Ghaemi, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

No evidence for interaction between 5-HT2A receptor and serotonin transporter genes in schizophrenia

A. Serretti, P. Artioli, Soo-Jung Lee, 2005, Neuroscience Research.

Quetiapine XR: Current status for the treatment of major depressive disorder

P. Masand, A. Serretti, D. Steffens, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry.

P. Masand, A. Patkar, Changsu Han, 2009, Contemporary clinical trials.

Temperament and character dimensions in patients with atopic dermatitis

C. Pae, Chul Lee, Tae-Suk Kim, 2006, The Journal of dermatology.

BanI Polymorphism of the Cytosolic Phospholipase A2 Gene and Mood Disorders in the Korean Population

A. Serretti, Soo-Jung Lee, C. Pae, 2004, Neuropsychobiology.

Triple Reuptake Inhibitors: The Next Generation of Antidepressants

A. Patkar, C. Pae, D. M. Marks, 2008, Current neuropharmacology.

Triple Reuptake Inhibitors: A Premise and Promise

A. Patkar, C. Pae, D. M. Marks, 2008, Psychiatry investigation.

Contribution of Personality Traits, Psychological Factors, and Health-Related Quality of Life to Medication Adherence in Patients with Rheumatoid Arthritis

C. Pae, J. Min, J. Koh, 2020, Yonsei medical journal.

Methylphenidate Extended Release (OROS MPH) for the Treatment of Antidepressant-Related Sexual Dysfunction in Patients With Treatment-Resistant Depression: Results From a 4-Week, Double-Blind, Placebo-Controlled Trial

P. Masand, A. Patkar, Changsu Han, 2009, Clinical neuropharmacology.

Sickness absence indicating depressive symptoms of working population in South Korea.

S. Jeon, A. Patkar, Changsu Han, 2018, Journal of affective disorders.

Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder.

A. Serretti, Soo-Jung Lee, A. Patkar, 2015, Journal of psychiatry & neuroscience : JPN.

The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder

P. Masand, A. Serretti, L. Mandelli, 2017, Advances in Therapy.

Dilemma for enhancing psychiatrists’ adherence to guideline (evidence)-based practice

Soo Jung Lee, P. Masand, A. Patkar, 2013, Expert review of neurotherapeutics.

Switching to quetiapine in patients with acute mania who were intolerant to risperidone

Soo-Jung Lee, C. Pae, I. Paik, 2004, Human psychopharmacology.

Posttraumatic Growth and Resilience: Assessment and Clinical Implications

J. Chae, S. Jeon, C. Pae, 2015 .

Filicide: Needing Psychiatrists' Attention

C. Pae, 2014, Psychiatry investigation.

Second-generation antipsychotics in the treatment of major depressive disorder: current evidence

P. Masand, Soo-Jung Lee, A. Patkar, 2013, Expert review of neurotherapeutics.

The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study

P. Masand, Soo-Jung Lee, A. Patkar, 2019, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

A 13-Week, Randomized Double-Blind, Placebo-Controlled, Cross-Over Trial of Ziprasidone in Bipolar Spectrum Disorder

P. Masand, P. Vöhringer, Sivan Mauer, 2015, Journal of clinical psychopharmacology.

Association of low dose trazodone treatment with aggravated angle‐closure glaucoma

Soo-Jung Lee, C. Pae, I. Paik, 2003, Psychiatry and clinical neurosciences.

Erratum: Correction of Acknowledgements Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update

P. Masand, Soo-Jung Lee, A. Patkar, 2019, Chonnam medical journal.

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update

P. Masand, Soo-Jung Lee, A. Patkar, 2016, Chonnam medical journal.

Five potential therapeutic agents as antidepressants: a brief review and future directions

P. Masand, Soo-Jung Lee, A. Patkar, 2015, Expert review of neurotherapeutics.

Criticisms of drugs in early development for the treatment of depression: what can be improved?

Changsu Han, C. Pae, Sheng-Min Wang, 2015, Expert opinion on investigational drugs.

The potential role of scopolamine as antidepressant for mood disorder.

C. Pae, 2014, Clinical neuropharmacology.

Scopolamine as an antidepressant.

C. Pae, 2013, Clinical neuropharmacology.

Relationship between Depression and Laryngopharyngeal Reflux

C. Pae, Y. Joo, Youn-Su Song, 2017, Psychiatry investigation.

Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study

Y. Shim, C. Pae, K. Cho, 2014, International Journal of Impotence Research.

fMRI investigation on cue-induced smoking craving.

S. Yoo, C. Pae, D. Kim, 2005, Journal of psychiatric research.

A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State

Megan M. Filkowski, P. Masand, P. Vöhringer, 2012, PloS one.

Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective

P. Masand, A. Patkar, C. Pae, 2009, Psychiatry investigation.

Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study

P. Masand, A. Patkar, Changsu Han, 2009, International clinical psychopharmacology.

Pregabalin augmentation to antidepressants in patients with major depressive disorder

C. Pae, 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Decreased plasma antioxidants in patients with Alzheimer's disease

Soo-Jung Lee, C. Pae, I. Paik, 2006, International journal of geriatric psychiatry.

A double-blind, placebo-controlled, parallel-group pilot study of milnacipran for chronic radicular pain (sciatica) associated with lumbosacral disc disease.

A. Patkar, C. Pae, D. M. Marks, 2014, The primary care companion for CNS disorders.

Aberration of cholesterol level in first-onset bipolar I patients.

Soo-Jung Lee, C. Pae, I. Paik, 2004, Journal of affective disorders.

Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis

B. Choe, T. Suh, C. Pae, 2005, Neuroscience Letters.

The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder.

Soo-Jung Lee, A. Patkar, Changsu Han, 2014, Journal of psychiatric research.

Low-frequency, Repetitive Transcranial Magnetic Stimulation for the Treatment of Patients with Posttraumatic Stress Disorder: a Double-blind, Sham-controlled Study

J. Chae, C. Pae, D. Nam, 2012, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Psychometric properties of the Korean version of the Short Post‐Traumatic Stress Disorder Rating Interview (K‐SPRINT)

J. Chae, J. Woo, C. Pae, 2008, Psychiatry and clinical neurosciences.

Manganese superoxide dismutase (MnSOD: Ala–9Val) gene polymorphism and mood disorders: A preliminary study

A. Patkar, C. Pae, I. Paik, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Increased plasma complement factor H is associated with geriatric depression

D. Steffens, B. Ham, A. Patkar, 2018, International Psychogeriatrics.

Agomelatine: a new option for treatment of depression?

C. Pae, 2014, Expert opinion on pharmacotherapy.

Desvenlafaxine Succinate: A Newer Antidepressant for the Treatment of Depression and Somatic Symptoms

P. Masand, H. Seo, A. Patkar, 2010, Postgraduate medicine.

Paroxetine: safety and tolerability issues.

P. Masand, B. Ham, A. Patkar, 2008, Expert opinion on drug safety.

Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice

Soo-Jung Lee, C. Pae, W. Bahk, 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Irritable bowel syndrome in psychiatric perspectives: a comprehensive review

P. Masand, A. Patkar, C. Pae, 2007, International journal of clinical practice.

A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome.

P. Masand, A. Patkar, C. Pae, 2009, Psychosomatics.

Polymorphism of the Serotonin Transporter Gene and Symptomatic Dimensions of Schizophrenia in the Korean Population

A. Serretti, Soo-Jung Lee, C. Pae, 2003, Neuropsychobiology.

Formula for predicting OSA and the Apnea–Hypopnea Index in Koreans with suspected OSA using clinical, anthropometric, and cephalometric variables

Ji-Eun Kim, C. Pae, Seung-Gul Kang, 2017, Sleep and Breathing.

Paroxetine: safety and tolerability issues

P. Masand, B. Ham, A. Patkar, 2008, Expert opinion on drug safety.

No Effect of Serotoninergic Gene Variants on Response to Interpersonal Counseling and Antidepressants in Major Depression

A. Serretti, P. Brambilla, M. Menchetti, 2013, Psychiatry investigation.

Impact of the tryptophan hydroxylase 1 gene A218C polymorphism on amygdala activity in response to affective facial stimuli in patients with major depressive disorder

B. Ham, C. Pae, I. Choi, 2009, Genes, brain, and behavior.

An open-label, single-arm pilot study to evaluate the efficacy of daily low dose tadalafil on depression in patients with erectile dysfunction.

C. Pae, Joon Chul Kim, J. Koh, 2019, Translational andrology and urology.

Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder

A. Patkar, Changsu Han, C. Pae, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone

A. Patkar, C. Pae, Min-Hyeon Park, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Risperidone in combination with mood stabilizers for acute mania: a multicentre, open study

C. Pae, Jin-Sang Yoon, Kwang-soo Kim, 2004, International clinical psychopharmacology.

Observational study to evaluate the clinical benefit of lamotrigine add‐on therapy in bipolar patients in a naturalistic treatment setting

J. G. Lee, C. Pae, B. Koo, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Clinical variables associated with early administration of antipsychotics in bipolar mania

P. Masand, Soo-Jung Lee, A. Patkar, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Potential role of pregabalin in the treatment of lithium-induced tremor: a case report.

A. Patkar, C. Pae, D. M. Marks, 2008, The international journal of neuropsychopharmacology.

Efficacy of antidepressants: bias in randomized clinical trials and related issues

P. Masand, Soo-Jung Lee, A. Patkar, 2018, Expert review of clinical pharmacology.

Post-Traumatic Growth: The Conception and Neurobiology

J. Chae, S. Jeon, C. Pae, 2015 .

How much to worry about the FDA warning in the use of citalopram?

C. Pae, Sheng-Min Wang, 2013, Expert review of neurotherapeutics.

Clinical Usefulness of Amisulpride Add-on Therapy in Schizophrenia Patients without Treatment Response to Second-generation Antipsychotics

Seong-Jin Cho, C. Pae, Seung-Gul Kang, 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion

P. Masand, D. Steffens, A. Patkar, 2007, Expert review of neurotherapeutics.

Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison

P. Masand, R. Emsley, A. Serretti, 2017, International clinical psychopharmacology.

Tools for Quality Evaluation of Clinical Research Reports

A. Patkar, Changsu Han, C. Pae, 2011 .

Mixed depression: a study of its phenomenology and relation to treatment response.

P. Vöhringer, N. Holtzman, S. Thommi, 2012, Journal of affective disorders.

Paroxetine in the treatment of depressed patients with haematological malignancy: an open‐label study

A. Serretti, Soo-Jung Lee, C. Pae, 2004, Human psychopharmacology.

Case–control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder

A. Serretti, A. Chiesa, Soo-Jung Lee, 2012, Psychiatry Research.

Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder

A. Patkar, C. Pae, 2013, CNS Drugs.

Clinical Issues in Use of Atypical Antipsychotics for Depressed Patients

A. Patkar, C. Pae, 2013, CNS Drugs.

Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder

A. Patkar, C. Pae, A. Forbes, 2011, CNS drugs.

Experiences and barriers to implementation of clinical practice guideline for depression in Korea

Changsu Han, C. Pae, Ho-Kyoung Yoon, 2013, BMC Psychiatry.

Achieving and Sustaining Remission in Bipolar I Disorder with Ziprasidone

P. Masand, C. Pae, F. Mandel, 2012, Clinical Drug Investigation.

Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice

Soo-Jung Lee, Changsu Han, C. Pae, 2015, Chonnam medical journal.

Measurement-based Treatment of Residual Symptoms Using Clinically Useful Depression Outcome Scale: Korean Validation Study

M. Zimmerman, S. Jeon, A. Patkar, 2017, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder

A. Serretti, A. Chiesa, Soo-Jung Lee, 2013, Psychiatry Research.

A Bibliometric Study on Second-generation Antipsychotic Drugs in the Asia–Pacific Region

F. López-Muñoz, C. Álamo, K. Sim, 2014 .

No influence of SLC6A3 40 base VNTR polymorphism on the response to risperidone

A. Serretti, A. Chiesa, A. Patkar, 2010, International journal of psychiatry in clinical practice.

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection

P. Masand, Soo-Jung Lee, A. Patkar, 2014, Neuropsychiatric Disease and Treatment.

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

P. Masand, Soo-Jung Lee, A. Patkar, 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Interrelationships among pain, disability, and psychological factors in young Korean conscripts with lumbar disc herniation.

Soo-Jung Lee, C. Pae, I. Paik, 2006, Military medicine.

Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.

B. Lerer, Soo-Jung Lee, A. Patkar, 2008, Journal of psychiatric research.

Tumor necrosis factor‐α gene polymorphism at position −308 and schizophrenia in the Korean population

A. Serretti, J. Chae, C. Pae, 2003, Psychiatry and clinical neurosciences.

Relationship of prolactin response to meta‐chlorophenylpiperazine with severity of drug use in cocaine dependence

A. Patkar, C. Pae, P. Mannelli, 2006, Human psychopharmacology.

Therapeutic possibilities of cysteamine in the treatment of schizophrenia.

C. Pae, I. Paik, Chul Lee, 2007, Medical hypotheses.

An Open-Label, Rater-Blinded, 8-Week Trial of Bupropion Hydrochloride Extended-Release in Patients with Major Depressive Disorder with Atypical Features

J. Seok, H. Jeon, H. Seo, 2013, Pharmacopsychiatry.

DRD2/ANKK1 TaqI A polymorphism affects corticostriatal activity in response to negative affective facial stimuli

B. Ham, W. Tae, Changsu Han, 2011, Behavioural Brain Research.

Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action

P. Masand, Soo-Jung Lee, A. Patkar, 2015, Psychiatry investigation.

Oral scopolamine augmentation for major depression

Changsu Han, C. Pae, 2013, Expert review of neurotherapeutics.

TAAR6 variations possibly associated with antidepressant response and suicidal behavior

A. Serretti, A. Patkar, C. Pae, 2010, Psychiatry Research.

Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials

J. Nelson, A. Patkar, C. Pae, 2013, CNS Spectrums.

Atypical Depression

P. Masand, A. Patkar, C. Pae, 2009, CNS drugs.

Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia.

P. Masand, Soo-Jung Lee, A. Patkar, 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

WORKING MEMORY PROCESSING OF FACIAL IMAGES IN SCHIZOPHRENIA: fMRI INVESTIGATION

S. Yoo, Soo-Jung Lee, C. Pae, 2005, The International journal of neuroscience.

Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.

M. Thase, A. Patkar, C. Pae, 2012, The Journal of clinical psychiatry.

Selegiline transdermal system in major depressive disorder

A. Patkar, C. Pae, Kimberly B Portl, 2012 .

Selegiline Transdermal System (STS) for Major Depressive Disorder (MDD) with Atypical Features: A Post-hoc Analysis of Data from an Open-label, 10-week Trial

A. Patkar, C. Pae, R. Mariani, 2012 .

Transdermal selegiline.

A. Patkar, C. Pae, M. Zarzar, 2007, Drugs of today.

Paroxetine mesylate: comparable to paroxetine hydrochloride?

P. Masand, B. Ham, A. Patkar, 2010, Expert opinion on pharmacotherapy.

Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder

Hyun-Ghang Jeong, S. Jeon, A. Patkar, 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises

J. Seok, B. Ham, H. Jeon, 2014, Psychiatry investigation.

Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: a multi-center, naturalistic study.

H. Jeon, H. Seo, Changsu Han, 2014, Journal of psychiatric research.

Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: a 12-week prospective open-label multicentre study

H. Jeon, Seong-Jin Cho, H. Seo, 2013, International clinical psychopharmacology.

Augmentation of Aripiprazole for Depressed Patients With an Inadequate Response to Antidepressant Treatment: A 6-Week Prospective, Open-Label, Multicenter Study

K. Min, H. Seo, C. Pae, 2013, Clinical neuropharmacology.

Management of Chronic Depressive Patients with Residual Symptoms

Changsu Han, C. Pae, T. Yeh, 2013, CNS Drugs.

A review of current evidence for vilazodone in major depressive disorder

P. Masand, Soo-Jung Lee, A. Patkar, 2013, International journal of psychiatry in clinical practice.

Comments on "Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials".

C. Pae, 2010, General hospital psychiatry.

Accelerating response to antidepressant treatment in depression: A possible role for atypical antipsychotics

C. Pae, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive–compulsive disorder

C. Pae, 2009, Psychiatry and clinical neurosciences.

Innovations in Clinical Research Design and Conduct in Psychiatry: Shifting to Pragmatic Approaches

C. Pae, D. M. Marks, David M. Marks, 2009, Psychiatry investigation.

Polymorphism of CTLA‐4 gene for major depression in the Korean population

J. Chae, C. Pae, Kwang-soo Kim, 2001, Psychiatry and clinical neurosciences.

Desvenlafaxine in the treatment of major depressive disorder

C. Pae, 2011, Expert opinion on pharmacotherapy.

Injured temporomandibular joint associated with fluoxetine-monotherapy-induced repeated yawning.

Soo-Jung Lee, C. Pae, I. Paik, 2003, General hospital psychiatry.

Characteristics of neurocognitive functions in mild cognitive impairment with depression

D. Steffens, Hyun-Ghang Jeong, S. Jeon, 2016, International Psychogeriatrics.

A review of current evidence for acetyl-l-carnitine in the treatment of depression.

P. Masand, Soo-Jung Lee, A. Patkar, 2014, Journal of psychiatric research.

Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression.

P. Masand, A. Serretti, F. Benedetti, 2019, Journal of affective disorders.

Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial

Hyun-Ghang Jeong, A. Patkar, Changsu Han, 2023, Frontiers in Psychiatry.

Ghrelin precursor gene polymorphism and methamphetamine dependence in the Korean population

I. Lyoo, C. Pae, D. Kim, 2005, Neurosciences research.

Early switch strategy in patients with major depressive disorder

Soo-Jung Lee, C. Pae, Sheng-Min Wang, 2012, Expert review of neurotherapeutics.

Does minocycline have antidepressant effect?

A. Patkar, Changsu Han, C. Pae, 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression

Changsu Han, C. Pae, Moon-Soo Lee, 2023, Clinical Psychopharmacology and Neuroscience.

Influence of the number and severity of somatic symptoms on the severity of depression and suicidality in community‐dwelling elders

S. Ryu, D. Steffens, Hyun-Ghang Jeong, 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

Paroxetine: current status in psychiatry

A. Patkar, C. Pae, 2007, Expert review of neurotherapeutics.

Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial.

S. Ryu, Ki Woong Kim, C. Pae, 2016, Journal of Alzheimer's disease : JAD.

The Association between Post-Stroke Depression and the Activities of Daily Living/Gait Balance in Patients with First-Onset Stroke Patients

Soo-Jung Lee, C. Pae, G. Park, 2016, Psychiatry investigation.

Effect of 5‐haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder

A. Serretti, L. Mandelli, Soo-Jung Lee, 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features.

P. Masand, A. Patkar, Changsu Han, 2008, Primary care companion to the Journal of clinical psychiatry.

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial

P. Masand, S. Jeon, A. Patkar, 2023, Clinical Psychopharmacology and Neuroscience.

Dysbindin gene (DTNBP1) and schizophrenia in Korean population

A. Serretti, L. Mandelli, A. Patkar, 2009, European Archives of Psychiatry and Clinical Neuroscience.

Quetiapine augmentation for depression: dosing pattern in routine practice

P. Masand, Soo-Jung Lee, A. Patkar, 2015, International clinical psychopharmacology.

Verbal Working Memory Dysfunction in Schizophrenia: An fMRI Investigation

S. Yoo, C. Pae, H. Lim, 2008, The International journal of neuroscience.

Head motion analysis during cognitive fMRI examination: Application in patients with schizophrenia

Seung-Schik Yoo, S. Yoo, C. Pae, 2005, Neuroscience Research.

Effect of nizatidine on olanzapine‐associated weight gain in schizophrenic patients in Korea: a pilot study

Soo-Jung Lee, C. Pae, I. Paik, 2003, Human psychopharmacology.

VNTR Polymorphism of Tyrosine Hydroxylase Gene and Schizophrenia in the Korean Population

A. Serretti, Soo-Jung Lee, C. Pae, 2003, Neuropsychobiology.

Curcumin as an add-on to antidepressive treatment.

C. Pae, 2013, Clinical neuropharmacology.

Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients.

P. Masand, A. Patkar, Changsu Han, 2009, Psychosomatics.

Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder

J. Chae, C. Pae, W. Bahk, 2006, Psychiatry and clinical neurosciences.

The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis

Soo-Jung Lee, C. Pae, G. Park, 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Do we need more than one antidepressant for patients with major depressive disorder?

Changsu Han, C. Pae, T. Jun, 2011, Expert review of neurotherapeutics.

Desvenlafaxine: a new antidepressant or just another one?

C. Pae, 2009, Expert opinion on pharmacotherapy.

Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS).

A. Patkar, C. Pae, Sungwon Jung, 2013, Journal of affective disorders.

Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.

C. Pae, I. Paik, Chul Lee, 2007, Medical hypotheses.

Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia

C. Pae, 2008, Psychiatry Research.

Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role

A. Serretti, Soo-Jung Lee, A. Patkar, 2018, Journal of Molecular Neuroscience.

Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication.

C. Pae, I. Paik, Chul Lee, 2005, The Journal of neuropsychiatry and clinical neurosciences.

Perspectives on the Happiness of Community-Dwelling Elderly in Korea

D. Steffens, Hyun-Ghang Jeong, S. Jeon, 2015, Psychiatry investigation.

Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.

P. Masand, A. Serretti, L. Mandelli, 2008, Neuro endocrinology letters.

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update

P. Masand, Soo-Jung Lee, A. Patkar, 2016, Chonnam medical journal.

The relationship between somatic symptoms and depression.

Soo-Jung Lee, Changsu Han, C. Pae, 2014, Neuro endocrinology letters.

Comments on “Addition of lamotrigine to valproic acid: A successful outcome in a case of rapid-cycling bipolar affective disorder”

A. Patkar, Changsu Han, C. Pae, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder

A. Serretti, A. Chiesa, Soo-Jung Lee, 2013, The Journal of international medical research.

International prescribing patterns for mood illness: the International Mood Network (IMN).

S. Strejilevich, P. Vöhringer, S. Ghaemi, 2014, Journal of affective disorders.

Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping

B. Choe, C. Pae, C. Lee, 2005, Neuroscience Research.

Socio-Demographic and Clinical Variables Associated with Chronic Homelessness among the Street Homeless People

C. Pae, S. Koh, H. Ko, 2016 .

Milnacipran: beyond a role of antidepressant.

P. Masand, B. Ham, A. Patkar, 2009 .

Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause.

P. Masand, A. Patkar, Changsu Han, 2009, Current opinion in investigational drugs.

Milnacipran for chronic pain in the orofacial region.

C. Pae, 2010, Clinical neuropharmacology.

Predictors of Response to Ziprasidone: Results from a 6-Week Randomized Double-Blind, Placebo-Controlled Trial for Acute Depressive Mixed State

N. Holtzman, S. Thommi, S. Ghaemi, 2012, Pharmacopsychiatry.

Efficacy of antidepressants: bias in randomized clinical trials and related issues.

P. Masand, A. Patkar, Changsu Han, 2018, Expert review of clinical pharmacology.

The association between personality traits and treatment outcomes in Korean patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a preliminary study.

Soo-Jung Lee, C. Pae, Joon Chul Kim, 2014, General hospital psychiatry.

TAAR 6 and HSP-70 variations associated with bipolar disorder

A. Serretti, L. Mandelli, C. Pae, 2009, Neuroscience Letters.

The Impact of Heat Shock Protein 70 Gene Variations on Clinical Presentation and Outcome in Schizophrenic Inpatients

A. Serretti, L. Mandelli, D. De Ronchi, 2009, Neuropsychobiology.

Beyond serotonin: newer antidepressants in the future

P. Masand, C. Pae, G. Rakesh, 2017, Expert Review of Neurotherapeutics.

Influence of TAAR6 polymorphisms on response to aripiprazole

A. Serretti, L. Mandelli, A. Chiesa, 2009, Progress in Neuro-psychopharmacology and Biological Psychiatry.

PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study

A. Serretti, Soo-Jung Lee, A. Patkar, 2016, Neuropsychobiology.

Dilemma for enhancing psychiatrists’ adherence to guideline (evidence)-based practice

Soo Jung Lee, P. Masand, A. Patkar, 2013, Expert review of neurotherapeutics.

Dilemma for enhancing psychiatrists' adherence to guideline (evidence)-based

P. Masand, A. Patkar, Changsu Han, 2013 .

The association between the severity of poststroke depression and clinical outcomes after first-onset stroke in Korean patients.

Soo-Jung Lee, C. Pae, G. Park, 2015, General hospital psychiatry.

The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: an exploratory study.

A. Serretti, Soo-Jung Lee, C. Pae, 2014, Journal of psychosomatic research.

Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population

J. Woo, C. Pae, K. Yoon, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Impact of the tryptophan hydroxylase 1 gene A218C polymorphism on amygdala activity in response to affective facial stimuli in patients with major depressive disorder

B. Ham, C. Pae, Bong-June Yoon, 2009, Genes, brain, and behavior.

Epistatic Interactions between CREB and CREM Variants in Affective Disorder

A. Serretti, A. Chiesa, Soo-Jung Lee, 2014, Psychiatry investigation.

Investigation of epistasis between DAOA and 5HTR1A variants on clinical outcomes in patients with schizophrenia.

Soo-Jung Lee, Alessandro Serretti, A. Serretti, 2013, Genetic testing and molecular biomarkers.

Tumor necrosis factor‐β gene polymorphism may not be associated with major depressive disorder in the Korean population

J. Chae, C. Pae, Kwang-soo Kim, 2003, Psychiatry and clinical neurosciences.

P.4.01 C-X-C chemokine signalling is implicated in major depressive disorder in a sample of Korean elderly subjects

A. Serretti, C. Pae, C. Fabbri, 2019, European Neuropsychopharmacology.

Sertindole: dilemmas for its use in clinical practice

C. Pae, 2013, Expert opinion on drug safety.

Drug Safety Evaluation

P. Masand, A. Patkar, C. Pae, 2008 .

Comments on “Low plasma BDNF is associated with suicidal behavior in major depression” by Y.K. Kim et al. Progress in Neuropsychopharmacology and Biological Psychiatry 2006 Aug 9; [Epub ahead of print]

C. Pae, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial

P. Masand, S. Jeon, A. Patkar, 2023, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Effectiveness and tolerability of paroxetine controlled release (CR) in the treatment of major depressive disorder: an open‐label, prospective, multi‐center trial in Korea

K. Min, C. Pae, Sang-Yeol Lee, 2007, Human psychopharmacology.

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat

A. Serretti, Soo-Jung Lee, C. Pae, 2021, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting

P. Masand, A. Patkar, Changsu Han, 2023, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Attitudes on clinical research participation of community living elders in Korea

B. Ham, A. Patkar, C. Pae, 2012 .

Precision medicine for psychopharmacology: a general introduction

A. Patkar, Changsu Han, C. Pae, 2016, Expert review of neurotherapeutics.

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

P. Masand, S. Jeon, A. Patkar, 2022, Psychiatry investigation.

A Severe Case of Bupropion Hydrochloride Extended-Release Monotherapy-Associated Visual Hallucinations and Delirium in a Female Patient with Major Depressive Disorder

C. Pae, 2010, CNS Spectrums.

Effect of the Dysbindin Gene on Antimanic Agents in Patients with Bipolar I Disorder

A. Serretti, L. Mandelli, D. De Ronchi, 2008, Psychiatry investigation.

Comparison of Risperidone Orodispersible Tablet and Intramuscular Haloperidol in the Treatment of Acute Psychotic Agitation: A Randomized Open, Prospective Study

C. Pae, H. Lim, I. Paik, 2010, Neuropsychobiology.

Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial.

P. Masand, Soo-Jung Lee, A. Patkar, 2007, The Journal of clinical psychiatry.

Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: a preliminary trial

Soo-Jung Lee, C. Pae, I. Paik, 2005, International clinical psychopharmacology.

P. Masand, A. Patkar, Changsu Han, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Use of antidepressants for depression in patients with Parkinson's disease

C. Pae, 2013, Expert opinion on pharmacotherapy.

Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting

C. Pae, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Available therapies and current management of fibromyalgia: focusing on pharmacological agents.

H. Seo, C. Pae, J. Koh, 2011, Drugs of today.

Comments on “Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder”

C. Pae, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Antipsychotics and abnormal liver function tests.

C. Pae, 2012, Clinical neuropharmacology.